Moderna's Flu Vaccine Success Boosts COVID-19 Combo Shot Prospects
Moderna's experimental mRNA flu vaccine showed stronger immune responses than existing vaccines in a late-stage trial, paving the way for approval and the development of a combined COVID and flu vaccine, with plans to resubmit applications later this year amid regulatory discussions.